Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy ...

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical ...

Radiation therapy is often thought of as a treatment that only has a role in early-stage disease. This is no longer the case, and this approach to treatment can be used in several different ways even ...

For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...

After skin cancer, prostate cancer is the most commonly diagnosed cancer among men in the United States. In fact, one in eight men will be diagnosed with prostate cancer during their lifetime, ...

People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower ...

LOS ANGELES (KABC) -- Proton therapy to treat prostate cancer has been available in Southern California for nearly 35 years. It's less invasive and offers fewer side effects compared to conventional ...

Shares of Alpha Tau Medical rose Wednesday after it said it will collaborate with Tolmar International to bring localized alpha radiation cancer therapy to prostate cancer patients in the United ...

Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...